Wells Fargo & Company Celcuity Inc. Transaction History

Wells Fargo & Company

$410 Billion
Q1 2024

A detailed history of Wells Fargo & Company transactions in Celcuity Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 6,425 shares of CELC stock, worth $111,024. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,425

Previous 5,342 20.27%

Holding current value

$111,024

Previous $77,000 79.22%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$13.74 - $21.6 $14,880 - $23,392	1,083 Added 20.27%	6,425 $138,000
Q4 2023 Feb 09, 2024	BUY	$8.7 - $15.02 $9,230 - $15,936	1,061 Added 24.78%	5,342 $77,000
Q3 2023 Nov 13, 2023	SELL	$8.96 - $10.75 $20,177 - $24,209	-2,252 Reduced 34.47%	4,281 $39,000
Q2 2023 Aug 15, 2023	BUY	$9.39 - $12.18 $60,518 - $78,500	6,445 Added 7323.86%	6,533 $71,000
Q1 2023 May 12, 2023	BUY	$9.4 - $12.82 $404 - $551	43 Added 95.56%	88 $0

Q4 2022 Feb 13, 2023	SELL	$7.55 - $14.01 $520,731 - $966,283	-68,971 Reduced 99.93%	45 $0
Q3 2022 Nov 14, 2022	SELL	$8.0 - $10.64 $364,264 - $484,471	-45,533 Reduced 39.75%	69,016 $692,000
Q2 2022 Aug 12, 2022	SELL	$5.35 - $10.11 $841,266 - $1.59 Million	-157,246 Reduced 57.85%	114,549 $1.04 Million
Q1 2022 May 16, 2022	BUY	$7.93 - $13.33 $433,739 - $729,097	54,696 Added 25.19%	271,795 $2.54 Million
Q4 2021 Feb 14, 2022	BUY	$11.96 - $19.35 $192,376 - $311,244	16,085 Added 8.0%	217,099 $2.86 Million
Q3 2021 Nov 15, 2021	BUY	$17.35 - $24.87 $2.27 Million - $3.26 Million	130,982 Added 187.03%	201,014 $3.62 Million
Q2 2021 Aug 16, 2021	BUY	$14.25 - $30.93 $997,272 - $2.16 Million	69,984 Added 145800.0%	70,032 $1.68 Million
Q1 2021 May 13, 2021	BUY	$10.43 - $17.8 $156 - $267	15 Added 45.45%	48 $1,000
Q4 2020 Feb 09, 2021	SELL	$5.13 - $11.72 $2,436 - $5,567	-475 Reduced 93.5%	33 $0
Q3 2020 Nov 05, 2020	SELL	$5.1 - $7.07 $2,789 - $3,867	-547 Reduced 51.85%	508 $3,000
Q2 2020 Aug 13, 2020	SELL	$4.42 - $11.04 $61,641 - $153,963	-13,946 Reduced 92.97%	1,055 $7,000
Q1 2020 May 14, 2020	BUY	$5.79 - $11.78 $86,855 - $176,711	15,001 New	15,001 $97,000

Others Institutions Holding CELC

# of Institutions

Shares Held

22.9M

Call Options Held

24.9K

Put Options Held

View Full List

About Celcuity Inc.

Ticker CELC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,941,300
Market Cap $258M
Description
Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...

More about CELC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Celcuity Inc. Transaction History